Christobel Selecky, a director at $IBRX, sold 25,000 shares of the company on 02-23-2026 for an estimated $250,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $IBRX stock.
$IBRX Insider Trading Activity
$IBRX insiders have traded $IBRX stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $IBRX stock by insiders over the last 6 months:
- BARRY J. SIMON has made 0 purchases and 4 sales selling 326,967 shares for an estimated $2,877,898.
- CHRISTOBEL SELECKY has made 0 purchases and 3 sales selling 100,000 shares for an estimated $687,650.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IBRX Hedge Fund Activity
We have seen 137 institutional investors add shares of $IBRX stock to their portfolio, and 110 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 7,764,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $19,099,440
- HEIGHTS CAPITAL MANAGEMENT, INC removed 6,565,709 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $13,000,103
- BLACKROCK, INC. added 5,790,256 shares (+29.2%) to their portfolio in Q4 2025, for an estimated $11,464,706
- STATE STREET CORP added 5,139,890 shares (+45.4%) to their portfolio in Q4 2025, for an estimated $10,176,982
- VANGUARD GROUP INC added 5,122,052 shares (+18.5%) to their portfolio in Q4 2025, for an estimated $10,141,662
- GOLDMAN SACHS GROUP INC added 5,012,001 shares (+439.4%) to their portfolio in Q4 2025, for an estimated $9,923,761
- CITIGROUP INC removed 2,271,488 shares (-95.4%) from their portfolio in Q4 2025, for an estimated $4,497,546
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IBRX Analyst Ratings
Wall Street analysts have issued reports on $IBRX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 02/23/2026
- D. Boral Capital issued a "Buy" rating on 01/20/2026
- Piper Sandler issued a "Overweight" rating on 01/20/2026
To track analyst ratings and price targets for $IBRX, check out Quiver Quantitative's $IBRX forecast page.
$IBRX Price Targets
Multiple analysts have issued price targets for $IBRX recently. We have seen 5 analysts offer price targets for $IBRX in the last 6 months, with a median target of $9.0.
Here are some recent targets:
- Andres Y. Maldonado from HC Wainwright & Co. set a target price of $15.0 on 02/23/2026
- Jason Kolbert from D. Boral Capital set a target price of $23.0 on 02/23/2026
- Justin Zelin from BTIG set a target price of $9.0 on 01/23/2026
- Joseph Catanzaro from Piper Sandler set a target price of $7.0 on 01/20/2026
- Kelly Shi from Jefferies set a target price of $9.0 on 12/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
